Free Cash Flow Build Up

Aerie Pharmaceuticals, Inc. (AERI)

$7.5

-0.30 (-3.85%)
Year
A/P
Revenue
EBITDA
EBIT
Tax Rate
EBIAT
Depreciation
Accounts Receivable
Inventories
Accounts Payable
Capital Expenditure
UFCF
WACC
PV UFCF
SUM PV UFCF